Acura Hit With Securities Suit Over Acurox Claims
A shareholder has filed a putative securities fraud class action against Acura Pharmaceuticals Inc., claiming the drugmaker misrepresented the chances that its flagship painkiller would gain U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article